PPLPHARMA - IntraDay Trade Analysis with Live Signals

Last Updated Time : 19 Sept 25, 2:16 pm

IntraDay Trade Rating: 3.7

💊 Intraday Trading Analysis for PPLPHARMA

📊 Technical & Momentum Overview

Current Price: ₹203 — trading above 50 DMA (₹199) and just below 200 DMA (₹205), signaling a potential breakout zone.

RSI at 59.0: Bullish momentum, nearing overbought territory but still favorable for continuation.

MACD at 2.31: Positive crossover, supporting upward price action.

Volume: 18.9L vs 31.0L average — below average, suggesting moderate intraday interest.

📈 Fundamental Snapshot

P/E of 37.6 vs Industry PE of 33.4: Slightly overvalued.

ROCE (12.4%) & ROE (9.74%): Moderate efficiency.

Quarterly PAT Drop: ₹277 Cr → ₹113 Cr — significant decline, may weigh on sentiment.

PEG Ratio of 1.69: Fairly valued relative to growth.

Institutional Activity: FII (-0.63%) and DII (-0.53%) reduced holdings — mildly negative.

Debt-to-Equity (0.17): Financially stable.

🎯 Intraday Strategy

✅ Optimal Buy Price

Buy Zone: ₹200–₹203

Entry near 50 DMA with tight stop-loss; confirm with MACD slope and RSI holding above 58.

💰 Profit-Taking Levels

Target 1: ₹207 (200 DMA resistance)

Target 2: ₹212 (next resistance zone)

Aggressive Target: ₹218+ only if RSI crosses 62 and MACD accelerates

🛡️ Stop-Loss

Stop-Loss Level: ₹196

Breach below this level signals breakdown risk and invalidates intraday setup.

🕒 Exit Strategy If Already Holding Today

Exit on Strength

If price nears ₹212–₹218 and RSI rises above 62 with volume surge, consider booking profits.

Exit on Weakness

If MACD flattens or RSI drops below 56 with price rejection at ₹207, exit partially.

Full exit if price breaks below ₹196 with rising volume.

PPLPHARMA offers a moderately favorable setup for intraday trading today, especially if price sustains above ₹200 and volume improves. Let me know if you'd like to track this live or compare with other pharma stocks showing stronger momentum.

Edit in a page